Canaccord Genuity Starts Insmed (INSM) at Buy
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $119.36 +0.86%
Rating Summary:
32 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 13 | New: 48
Rating Summary:
32 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 13 | New: 48
Join SI Premium – FREE
Canaccord Genuity initiates coverage on Insmed (NASDAQ: INSM) with a Buy. PT $12.00.
For an analyst ratings summary and ratings history on Insmed click here. For more ratings news on Insmed click here.
Shares of Insmed closed at $6.83 yesterday.
For an analyst ratings summary and ratings history on Insmed click here. For more ratings news on Insmed click here.
Shares of Insmed closed at $6.83 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Assumes Insmed (INSM) at Buy
- TMX Group closes C$1.1 billion private placement debenture offering
- Osisko Critical Minerals raises private placement target to C$250M
Create E-mail Alert Related Categories
New CoverageRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
